Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

70 results about "Alkalizing agent" patented technology

Alkalinizing agents are drugs used to manage disorders associated with low pH. For example, they may be used to treat acidosis due to renal failure. Used for oral or parenteral therapy, sodium bicarbonate is the commonly preferred alkalinizing agent.

Natural plant hair dye and preparation method thereof

The invention relates to natural plant hair dye, which comprises a bean extract, a lucid ganoderma extract, an astragalus extract, a polygonum multiflorum extract, vegetable fat, erythritol, L-proline, ferulic acid and gamma-aminobutyric acid, does not contain phenylenediamine, resorcinol, ammonium hydroxide, a vaccinium bracteatum thunb leaf extract and other components at all, and does not need to additionally add a thickening agent, a care agent and an alkalizing agent. The hair dye is good in hair dyeing effect, safe, reliable and non-irritant.
Owner:GUANGZHOU DAMAO RESEARCH TECHNOLOGY CO LTD

Pharmaceutical compositions of oral GLP agonists

The present invention relates to a pharmaceutical composition for oral administration comprising a GLP receptor agonist or a pharmaceutically acceptable salt or derivative thereof, one or more penetration enhancers, one or more mucous membrane adhesives, and one or more basifying agents. More preferably, the penetration enhancer is a penetration enhancer based on medium chain fatty acids.
Owner:ANYA BIOPHARM INC +2

Hair dyeing composition with improved durability

A dyeing composition for keratin fibers, including one or more first direct dyes selected from HC Blue 18, HC Red 18, HC Yellow 16, and salts thereof, one or more second direct dyes selected from Disperse Black 9, Acid Yellow 1, 2-amino-6-chloro-4-nitrophenol and salts thereof, and one or more alkalizing agents.
Owner:KAO CORP

Hair styling composition

A hair styling composition containing: a) one or more anionic hair styling polymer(s), b) one or more alkalizing agents, c) one or more monoalcohols, wherein the total concentration of water in the hair styling composition is 10% by weight or less.
Owner:KAO GERMANY GMBH

Soybean protein glue film as well as preparation method and application thereof

The invention discloses a soybean protein adhesive film and a preparation method thereof. The soybean protein adhesive film is prepared from the following raw materials: 6 parts of soybean protein, 0.1-1 part of an alkalizer, 0.5-5 parts of a protein denaturant, 1.2-2.4 parts of a polyol plasticizer and 30-60 parts of a solvent. The preparation method comprises the following steps: S1, dispersing soybean protein in a solvent to form a suspension, adding an alkalizer and a protein denaturant to obtain a mixed solution A, and heating and stirring for protein denaturation treatment to obtain a denatured soybean protein solution; s2, adding a polyol plasticizer into the modified soybean protein solution, and uniformly mixing to obtain a film forming solution; s3, coating a substrate with the film forming liquid to form a wet film; and S4, drying the wet film to obtain the soybean protein glue film. By reasonably using the basifier, the protein denaturant and the plasticizer, the solid content of the soybean protein adhesive film is improved, so that the prepared soybean protein adhesive film exists in a solid adhesive film form, the amount of water needing to be evaporated in the hot pressing process is reduced, and the problem that the solid content of traditional liquid soybean meal adhesive is low is thoroughly solved.
Owner:SOUTHWEST FORESTRY UNIVERSITY

Compositions and methods for altering the color of hair

The disclosure relates to compositions for altering the color of keratin fibers and methods of using the compositions. The compositions comprise (a) a bonding system comprising: (i) at least one first bonding agent chosen from citric acid and / or salts thereof, and (ii) at least one second bonding agent chosen from amino acids, amino sulfonic acids, salts thereof, or combinations thereof; (b) at least one fatty alcohol; (c) at least one fatty acid; (d) at least one alkyl polyglucoside; (e) at least one alkalizing agent; and (f) at least one solvent. The compositions can further comprise one or more oxidation dyes, couplers, oxidizing agents, or combinations thereof.
Owner:LOREAL SA

Bleaching and coloring composition for keratin fibers comprising direct dyes

A bleaching and coloring composition for keratin fibers, including one or more alkalizing agents, one or more bleaching compounds, HC Blue 18 and / or a salt thereof, and tetrabromophenol blue and / or a salt thereof. A method for bleaching and coloring of keratin fibers, including mixing the bleaching and coloring composition with a second aqueous composition including hydrogen peroxide as one or more oxidizing agents and having a pH in the range of 1 to 6 to yield a ready-to-use composition having a pH in the range of 7 to 12, applying the ready-to-use composition onto the keratin fibers and leaving it for a time period of 1 to 60 min, and optionally heating the keratin fibers to a temperature in the range of 30° C. to 60° C., and rinsing-off the keratin fibers and optionally drying the keratin fibers.
Owner:KAO CORP

Cyclobenzaprine treatment for fibromyalgia

PendingUS20260108477A1Organic active ingredientsNervous disorderCyclobenzaprine hclCyclobenzaprine
Methods for treating fibromyalgia and one or more of its associated symptoms of pain, sleep disturbance and / or fatigue comprising administering to a subject in need thereof, 5.6 mg cyclobenzaprine HCl per day in one or more dosage units by transmucosal administration, the cyclobenzaprine HCl being in a form of a eutectic, and the one or more dosage units further comprising a basifying agent.
Owner:TONIX PHARMA LTD

Two-component hair care product, process for producing a cosmetic product and use of the two-component hair care product

Two-component hair care product comprising separately an anhydrous carrier as a first component and an aqueous carrier as a second component, characterized in that the anhydrous carrier a) a branched or unbranched alkane having a chain length of C10 to C30, in an amount of 20 to 90 wt.%, based on the total weight of the first component, b) a branched or unbranched fatty alcohol having a chain length of C8 to C22, in an amount of 5 to 40% by weight, based on the total weight of the first component, (c) an organic acid or an alkalizing agent and d) a pH-sensitive color indicator which shows a color change in the range between pH 3 and 6, in an amount of 0.0001 to 0.05% by weight, based on the total weight of the first component, and the aqueous carrier comprises a cationic surfactant comprising an organic radical with a chain length of C12 to C30, in an amount of 0.5 to 20% by weight, based on the total weight of the second component, wherein the weight ratio of the first component to the second component is 10 to 1 to 1 to 10, further characterized in that the first component and the second component are at a temperature of 20 °C and a pressure of 10 5 Pa are liquid.
Owner:HENKEL KGAA

Phenalene-1-one substituted with an anionic moiety, compositions comprising at least one phenalene-1-one, and uses therefor

Disclosed are novel phenalene-l-one photosensitizers capable of generating singlet oxygen, compositions comprising at least one novel phenalene-l-one photosensitizer, and uses of the novel phenalene-l-one photosensitizers. The compositions are bleaching compositions, comprising at least one phenalene-l-one photosensitizer, at least one persulfate, at least one alkalizing agent and at least one peroxide source. (Formula I)
Owner:WELLA GERMANY GMBH

Medical treatment comprising enteral administration of edaravone

The invention relates to a solid water-dispersible pharmaceutical composition for use in the treatment of a disease, said treatment comprising dispersing said pharmaceutical composition into an aqueous liquid to produce an enteraliy administrable liquid containing at least 0.5 gram of said pharmaceutical composition and at least 0.3 g / 1 of edaravone, followed by enteral administration of said enteraliy administrable liquid to a human patient in an amount to provide a dose of 30-300 mg of edaravone, said pharmaceutical composition comprising: 2-50 weight % of 3-methyl-l-phenyl-2-pyrazolin-5-one (edaravone); and 3-50 weight % of a water-soluble alkalizing agent. This solid composition containing edaravone can be easily dispersed in an aqueous liquid to prepare an aqueous solution of edaravone that can be ingested by a patient. The solid composition of the invention provides the advantage that when the composition is introduced into water the edaravone dissolves very rapidly and the enteraliy administrable liquid thus obtained has a high oral bioavailability.
Owner:CUIWEI TW001 CO

Bleaching composition for keratin fibres

The present invention relates to a bleaching and / or lightening composition A for keratin fibres, preferably human keratin fibres, more preferably human hair, comprising: a) tris (hydroxymethyl) aminomethane and / or 2-amino-2-methyl-1, 3-propanediol, and / or salts thereof, and / or mixtures thereof; b) one or more inorganic basifying agents, c) one or more ammonium salts or alkali metal salts or alkaline earth metal salts of peroxysulfates or peroxysulfates.
Owner:KAO CORP

Method for manufacturing carboxymethyl cellulose particles, carboxymethyl cellulose particles manufactured thereby, and absorbent article comprising the same

ActiveJP2025024043AAbsorbent padsBaby linensCarboxymethyl celluloseMethylating Agent
To provide a method for manufacturing CMC particles having excellent blood absorbency, centrifuge retention capacity (CRC), and absorbency under load (AUL).SOLUTION: There are provided a method for manufacturing carboxymethyl cellulose particles, cellulose derivative particles manufactured by the method, and an absorbent article comprising same, wherein the method comprises: a step of reacting a cellulose raw material with an alkalizer to obtain alkalized cellulose; a step of reacting the alkalized cellulose with a carboxy methylating agent to obtain carboxymethyl cellulose; a primary cross-linking step of reacting the carboxymethyl cellulose with a core cross-linker to obtain a slurry-state carboxymethyl cellulose cross-linked body; a step of filtering the slurry-state carboxymethyl cellulose cross-linked body, followed by cleaning and dehydration; a secondary cross-linking step of reacting the carboxymethyl cellulose cross-linked body undergoing step with a surface cross-linker to obtain carboxymethyl cellulose having a core-shell structure; and a step of drying and pulverizing the carboxymethyl cellulose having a core-shell structure to obtain carboxymethyl cellulose particles having a core-shell structure.SELECTED DRAWING: Figure 2
Owner:LOTTE FINE CHEMICAL CO LTD

Oral pharmaceutical composition of pitavastatin, method and uses thereof

The present disclosure relates to a solid oral pharmaceutical composition comprising a therapeutically effective amount of pitavastatin or a pharmaceutically acceptable salt, an alkalizing agent and colloidal silicon dioxide. Furthermore, the present disclosure also relates to said composition further comprising a therapeutically effective amount of Ezetimibe.
Owner:TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA

Compositions for bleaching and coloring keratin fibers containing direct dyes

The present invention relates to a bleaching and coloring composition for keratin fibers, preferably for human keratin fibers, more preferably for human hair, comprising one or more alkalizing agents, one or more bleaching compounds, HC Blue 18 and / or its salts, tetrabromophenol blue and / or its salts.
Owner:KAO CORP

Hair coloring compositions comprising 2-amino-1-propanol as alkalising agents

ActiveUS12564545B2Cosmetic preparationsHair cosmeticsPropanolHair bleach
The presently claimed invention relates to hair colouring formulations comprising 2-amino-1-Propanol (2A1P / Alanilol) as an alkalizing agent. The compositions of the presently claimed invention provide a series of desirable properties to the user such as a pleasant low chemical odour and a high level of hair bleaching with an acceptable damage profile. The compositions of the presently claimed invention further enable formulators to deliver a wider range of shades or colour formulations by reducing the off-toning adducts of oxidative dyes.
Owner:WELLA GERMANY GMBH

Compositions and processes for modifying hair color.

Compositions and Processes for Modifying Hair Color: The disclosure relates to compositions for modifying the color of keratin fibers and processes for using the compositions. The compositions include (a) a bonding system comprising (i) at least one first bonding agent selected from alpha-hydroxy acids comprising at least three hydrogen-donating carboxyl groups and / or their salts; (ii) at least one second bonding agent selected from glycine and / or its salts; and (iii) optionally, at least one third bonding agent selected from aminosulfonic acids and / or their salts; (b) at least one fatty alcohol; (c) at least one fatty acid; (d) at least one alkyl polyglucoside; (e) at least one alkalizing agent; and (f) at least one solvent. The compositions may further comprise one or more oxidation dyes, couplers, oxidizing agents, or combinations thereof. Figure: None
Owner:LOREAL SA

Capsule-Filling Liquid Composition Containing Acetylcysteine

PendingKR1020260113186ASoftgelPolyethylene glycol
The present invention relates to a liquid composition for capsule filling containing acetylcysteine ​​and a soft capsule formulation containing the same. The liquid composition for capsule filling according to the present invention comprises acetylcysteine, polyethylene glycol having an average molecular weight of 300 to 600, and an alkalizing agent. The liquid composition for capsule filling according to the present invention can be used as a filler for soft capsule formulations and can improve the storage stability of acetylcysteine ​​even in the form of a liquid composition. In addition, the soft capsule formulation according to the present invention can exhibit dissolution characteristics of acetylcysteine ​​under various pH conditions.
Owner:TREEWEAVE CO LTD

Oral pharmaceutical composition of pitavastatin and ezetimibe, method and uses thereof

The present disclosure relates to a solid oral pharmaceutical composition comprising a therapeutically effective amount of pitavastatin or a pharmaceutically acceptable salt, an alkalizing agent and colloidal silicon dioxide. Furthermore, the present disclosure also relates to said composition further comprising a therapeutically effective amount of Ezetimibe.
Owner:TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA

Dirt deposition treatment method for secondary side of steam generator of nuclear power plant

The invention discloses a method for treating dirt deposition on the secondary side of a steam generator of a nuclear power plant, which comprises the following steps of: filtering and measuring the content of corrosion products in each water supply system of the nuclear power plant by adopting a sampling device with the filtering precision less than or equal to 0.4 mu m; each water supply system of the nuclear power plant comprises a steam drainage system, a condensation water system and a main water supply system. Adding a mixed alkalizer of ethanolamine and ammonia into the steam drainage system to increase the pH value of the steam drainage system; and adding a polyacrylic acid dispersing agent into the main water supply system. By applying the secondary side dirt deposition treatment method for the nuclear power plant steam generator, secondary side dirt deposition of the nuclear power plant steam generator can be effectively reduced. Effective reduction of dirt deposition on the secondary side of the steam generator of the nuclear power plant not only facilitates prolonging of the service life of steam generator equipment, but also is the key of prolonging of the service life of the steam generator from 40 years to 60 years, and unnecessary maintenance and labor cost and overhaul period of a nuclear power unit can be saved.
Owner:YANGJIANG NUCLEAR POWER

Hair dyeing composition comprising blue dye

The present invention relates to a dyeing composition for keratin fibers, comprising one or more alkalizing agents, HC blue 18 and / or its salts, tetrabromophenol blue and / or its salts. The present invention discloses a two-part composition, a kit and a dyeing method.
Owner:KAO CORP

Compositions and methods of hair color modification.

Compositions and Methods for Modifying Hair Color: This disclosure relates to compositions for modifying the color of keratin fibers and methods for using the compositions. The compositions include (a) a bonding system comprising (i) at least one first bonding agent selected from citric acid and / or salts thereof, and (ii) at least one second bonding agent selected from amino acids, aminosulfonic acids, salts thereof, or combinations thereof; (b) at least one fatty alcohol; (c) at least one fatty acid; (d) at least one alkyl polyglucoside; (e) at least one alkalizing agent; and (f) at least one solvent. The compositions may further include one or more oxidizing dyes, couplers, oxidizing agents, or combinations thereof. Figure for abstract: 1
Owner:LOREAL SA

Hair-dyeing base composition comprising an improved alkalizing agent, multi-compartment kit comprising the composition, and methods of dying hair by using the same

PCT designated stage expiredWO2025012318A3Perylene derivativesEthoxy Compounds
A hair-dyeing base composition comprising an improved alkalizing agent is disclosed, being improved in terms of overall reduction of ammonia compounds, thus advantageously minimizing the concerns related thereto. Said composition provides a satisfactory colour hair coverage, without the malodour or harm to the scalp typically ascribable to ammonia compounds, at the same time being devoid of ingredients known to raise concerns of skin harmfulness, such as ethoxylated compounds, PEG and its derivatives, and silicones, as it includes a high percentage of natural compounds. The inventive composition is therefore significantly more healthy for the clients / consumers and hair stylists handling the same, while keeping high performance in hair-dyeing. A multi-compartment kit comprising said composition, a dye and an oxidizing component is also disclosed, as well as their use in permanently dyeing hair. Are also disclosed processes of producing said hair-dyeing base composition, as well as hair-dyeing methods encompassing the application of said composition to hair.
Owner:KEMON

An omeprazole enteric-coated capsule and its preparation method

The present invention provides an omeprazole enteric-coated capsule and a preparation method thereof. The omeprazole enteric-coated capsule comprises omeprazole enteric-coated pellets and a capsule shell. The omeprazole enteric-coated pellets sequentially comprise, from the inside to the outside: a blank drug core layer, a first protective layer, a drug-loading layer, a second protective layer, an isolation layer and an enteric-coated layer. For the omeprazole enteric-coated capsule prepared by the present invention, through the introduction of the first protective layer, the second protective layer, an alkalizing agent, etc., the drug has good stability and release property.
Owner:GUANGDONG YILI LUODING PHARMA

Oral pharmaceutical composition of pitavastatin, method and uses thereof

The present disclosure relates to a solid oral pharmaceutical composition comprising a therapeutically effective amount of pitavastatin or a pharmaceutically acceptable salt, an alkalizing agent and colloidal silicon dioxide. Furthermore, the present disclosure also relates to said composition further comprising a therapeutically effective amount of Ezetimibe.
Owner:TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA

Compositions and methods for modifying hair color.

Compositions and Methods for Changing Hair Color The disclosure relates to compositions for changing the color of keratinous fibers and methods of using the compositions. The compositions comprise (a) a binding system comprising (i) at least one first binding agent selected from lactic acid and / or salts thereof, and (ii) at least one second binding agent selected from amino acids and / or salts thereof; (b) at least one fatty alcohol; (c) at least one fatty acid; (d) at least one alkyl polyglucoside; (e) at least one alkalizing agent and (f) at least one solvent. The compositions may further comprise one or more of oxidation dyes, couplers, oxidizing agents or combinations thereof. Figure for abstract: none
Owner:LOREAL SA

Oral hygiene compositions and methods of use

Disclosed herein are oral hygiene compositions, dental flossing material, and methods of treatment using the same. In some embodiments, the oral hygiene composition comprises a remineralization agent, a prebiotic agent, and an alkalizing agent.
Owner:SMILE MAKERS LLC

Single-agent air-oxidative hair coloring product and method for producing single-agent air-oxidative hair coloring product

PCT designated stageWO2025203955A1Cosmetic preparationsHair cosmeticsGallic acid esterHair Coloring Agents
A single-agent air-oxidative hair coloring product according to an aspect of the present disclosure contains (A) gallic acid or a derivative thereof, (B) an alkalizing agent, and (C) an oxidative dye. A method for producing a single-agent air-oxidative hair coloring product containing a plurality of components including (A) gallic acid or a derivative thereof, (B) an alkalizing agent, and (C) an oxidative dye according to another aspect of the present disclosure comprises: adding component (A) to a stirring tank and stirring; adding component (B) to the stirring tank and stirring; and adding component (C) to the stirring tank and stirring. In another aspect of the present disclosure, component (A) is added to the stirring tank and stirred before component (B) is added to the stirring tank or after component (B) is added to the stirring tank and stirred.
Owner:HOYU CO LTD

Chewable fexofenadine tablets

PCT designated stageWO2026074306A1Pill deliveryGranular deliveryFexofenadineMannitol
This disclosure is also based on the discovery that it is possible to eliminate the sweetener from a fexofenadine zwitterion dihydrate suspension and still achieve satisfactory taste masking by including the sweetener solely in the external phase. In addition, this disclosure is based on the discovery that it is possible to use an inert matrix containing only mannitol when turning suspensions of fexofenadine zwitterion dihydrate into granules. Accordingly, this disclosure is directed to sugar-free chewable fexofenadine tablets comprising sprayed and dried fexofenadine granules comprising a mannitol matrix and a composition devoid of a sweetener, said composition comprising fexofenadine zwitterion dihydrate, a wetting agent, a binder, an alkalizing agent, and a buffer; and an external phase comprising a flavoring agent, a disintegrant, the wetting agent, a diluent, a sweetener, and one or more lubricant. The disclosure also includes methods of making these tablets. In one embodiment, the method of producing a sugar- free chewable fexofenadine tablet includes: generating fexofenadine granules by spraying and drying a liquid fexofenadine suspension devoid of a sweetener comprising fexofenadine zwitterion dihydrate, a wetting agent, a binder, an alkalizing agent, and a buffer onto a mannitol matrix; and compressing the fexofenadine granules with an external phase comprising a flavoring agent, a disintegrant, the wetting agent, a diluent, a sweetener, one or more lubricant.
Owner:OPELLA HEALTHCARE GRP SAS